Precision Neuroscience, a New York-based biotech startup and one of the leading rivals to Elon Musk’s Neuralink, is transforming how we understand and interact with brain–computer interfaces (BCIs).
Its mission: to empower people with paralysis to control computers using only their thoughts — and to do so less invasively than many imagine.
Rethinking Invasiveness: Brain Data Is Surface-Level
According to Dr. Ben Rapoport, cofounder and chief science officer of Precision Neuroscience, a key misunderstanding about BCIs is their level of invasiveness.
“Many people have the impression that the data that we care about is sort of everywhere inside [the brain],” Rapoport told Business Insider. “But the most important matter — gray matter — is right at the surface.”
Rather than requiring deep-brain penetration, Precision Neuroscience uses a thin-film implant embedded with 1,024 electrodes that sits gently atop the motor cortex.
This design allows patients with paralysis to control cursors, type, browse the internet, and even play games — all by thought.
